Jubilant Pharmova board okays Rs 800 crore NCD private placement, seeks Rs 2,500 cr member nod

Fund Raising View source PDF Explain this filing

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹930.00

prior close

₹914.70

announcement price

In-mkt

timing

Nifty Microcap 250market+0.8%+2.9% vs market

Pharmaceuticals peers, median of 167sector-0.1%+3.9% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.3

15m

-0.4

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.8+0.8+2.9-0.1+3.9

Next day

+2.2+1.0+1.1-0.1+2.3

+0.5+1.7-1.2-0.3+0.8

+0.4+0.1+0.3-1.0+1.3

+0.5+0.8-0.2-0.8+1.4

+1.3-0.9+2.2-2.3+3.6

-0.4-4.5+4.0-4.7+4.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jubilant Pharmova's board approved issuance of up to 80,000 NCDs of face value Rs 1 lakh each, aggregating up to Rs 800 crore, via private placement in one or more tranches. NCDs will be listed on BSE, tenure up to 5 years, coupon to be discovered via bidding. Also seeking shareholder approval via postal ballot to issue non-convertible debt securities up to Rs 2,500 crore outstanding at any time for one year.

Likely market impact

Shareholders to vote on enabling up to Rs 2,500 crore NCD issuance over one year, raising company debt without equity dilution.